AKAP13
Reaktivität: Human
WB, IHC, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
WB 1:300-5000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0.5 μg/μL
Buffer
0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Haltbarkeit
12 months
Target
AKAP13
(A Kinase (PRKA) Anchor Protein 13 (AKAP13))
Andere Bezeichnung
AKAP13
Hintergrund
Optional[synonyms]: A kinase (PRKA) anchor protein 13, A kinase anchor protein 13, A kinase anchoring protein, A-kinase anchor protein 13, AKAP 13, AKAP Lbc, AKAP-13, AKAP-Lbc, AKAP13, AKP13_HUMAN, ARHGEF13, Breast cancer nuclear receptor binding auxiliary protein, Breast cancer nuclear receptor-binding auxiliary protein, BRX, c lbc, FLJ11952, FLJ43341, Guanine nucleotide exchange factor Lbc, HA 3, HA3, Ht 31, Ht31, Human thyroid anchoring protein 31, Human thyroid-anchoring protein 31, LBC, LBC oncogene, Lymphoid blast crisis oncogene, Non oncogenic Rho GTPase specific GTP exchange factor, Non-oncogenic Rho GTPase-specific GTP exchange factor, P47, Protein kinase A anchoring protein 13, Protein kinase A-anchoring protein 13, PROTO LB, PROTO LBC.